WESPAC Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-23,709
| Closed | -$1.28M | – | 110 |
|
|
2015
Q4 | $1.28M | Buy |
+23,709
| New | +$1.28M | 1.48% | 25 |
|
|
2015
Q3 | – | Sell |
-16,686
| Closed | -$972K | – | 87 |
|
|
2015
Q2 | $972K | Sell |
16,686
-2,406
| -13% | -$140K | 0.73% | 54 |
|
|
2015
Q1 | $1.1M | Sell |
19,092
-384
| -2% | -$22.1K | 0.83% | 49 |
|
|
2014
Q4 | $983K | Sell |
19,476
-1,623
| -8% | -$81.9K | 0.69% | 55 |
|
|
2014
Q3 | $987K | Buy |
21,099
+6,879
| +48% | +$322K | 0.79% | 50 |
|
|
2014
Q2 | $640K | Sell |
14,220
-7,047
| -33% | -$317K | 0.73% | 57 |
|
|
2014
Q1 | $898K | Sell |
21,267
-360
| -2% | -$15.2K | 0.78% | 53 |
|
|
2013
Q4 | $851K | Buy |
21,627
+3,330
| +18% | +$131K | 0.71% | 60 |
|
|
2013
Q3 | $649K | Buy |
18,297
+6,375
| +53% | +$226K | 0.76% | 53 |
|
|
2013
Q2 | $396K | Buy |
+11,922
| New | +$396K | 0.6% | 65 |
|